Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study of YMN-A02, a Bifunctional RNA Agent, for Safety, Tolerability, and Preliminary Efficacy in Patients With Advanced Primary Liver Cancer Who Have Failed Standard of Care

NCT07580261 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07580261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07580261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study of YMN-A02, a Bifunctional RNA Agent, for Safety, Tolerability, and Preliminary Efficacy in Patients With Advanced Primary Liver Cancer Who Have Failed Standard of Care
Lead sponsor
West China Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 30, 2026
Completion date
June 30, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma